3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Histiocytosis
1
Head and Neck Neoplasms
1
Glioblastoma
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Irinotecan
4
Gemcitabine
4
130-nm albumin-bound paclitaxel
4
Albumin-Bound Paclitaxel
3
pembrolizumab
2
napabucasin
2
Ascorbic Acid
2
trifluridine tipiracil drug combination
1
pralsetinib
1
alectinib
1
Paclitaxel
1
Nivolumab
1
Leucovorin
1
KRN-330
1
Imatinib Mesylate
1
HhAntag691
1
Fluorouracil
1
Cyclophosphamide
1
Cisplatin
1
Capecitabine
1
Calcium Dobesilate
1
Bupivacaine
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Digestive System Diseases
×
Immunotherapy
×
Clear all
No trials found.